证券日报网讯福瑞达（600223）11月26日在互动平台回答投资者提问时表示，公司珂谧系列产品的生产 安排是产能适配、供应链优化及市场快速响应的阶段性布局；公司自有医疗器械资质将根据整体产品规 划和产能布局进行统筹运用，以更好地服务于品牌长远发展。 ...

Core Insights - The article highlights the impressive display of Furuida, a subsidiary of Lushang Group, at the third Chain Expo, showcasing its innovations in the beauty and health sectors, particularly in traditional Chinese medicine modernization and synthetic biology breakthroughs [1][10] - Furuida's achievements reflect Lushang Group's strategic focus on technological innovation and collaboration with research institutions like the Shandong Academy of Pharmaceutical Sciences [1][9] Product Matrix: Breakthroughs from Raw Materials to End Solutions - Furuida's exhibition presented a comprehensive range of products, integrating traditional Chinese medicine with modern technology, particularly addressing sensitive skin issues through advanced extraction techniques [5] - The company has made significant advancements in synthetic biology, particularly with its royal jelly acid series, which targets aging skin by utilizing engineered bacteria for efficient production [5] Green and Sustainable Practices - Furuida emphasizes sustainability throughout its supply chain, producing raw materials that meet international certification standards and utilizing biodegradable packaging that reduces degradation time by over 60% compared to traditional plastics [6] End Products and Light Medical Aesthetic Solutions - The company offers a wide array of products, including the Yilian hyaluronic acid series and the Ai'er Doctor micro-ecological skincare line, which have gained popularity and recognition for their innovative approaches to skin health [7] R&D Core: From Laboratory to Market - Furuida has established a robust R&D system that spans basic research to industrial application, particularly excelling in the field of hyaluronic acid with patented technologies that enhance its market competitiveness [8] Lushang Innovation Ecosystem: From Single Point Breakthroughs to Systemic Empowerment - Furuida's innovations are part of Lushang Group's broader strategy to integrate research and development with industry, supported by the Shandong Academy of Pharmaceutical Sciences, which has made significant contributions to the company's technological advancements [9] Conclusion: Advancing China's Global Influence in Manufacturing - Furuida's success at the Chain Expo and its global supply chain strategies illustrate the upgrading path of China's beauty and health industry, driven by technological innovation and sustainable practices [10]